JP3548175B2 - 結合改良のためのバイオアクティブ共役体による移植片表面の改質 - Google Patents

結合改良のためのバイオアクティブ共役体による移植片表面の改質 Download PDF

Info

Publication number: JP3548175B2
Authority: JP; Japan
Prior art keywords: implant; bioactive; cooh; titanium; bioactive molecule
Prior art date: 1993-05-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP52476394A

Other languages

English (en)

Japanese (ja)

Other versions

JPH08511696A (ja

Inventor

ナンスィ，アントニオ

マッキー，マルク・デ

サーシャー，エドワード

サバドーゴ，オウマロ

ウーエスト，ジェームズ

Original Assignee

ユニヴェルスィテ・ドゥ・モントリオール

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-10

Filing date

1994-05-09

Publication date

2004-07-28

1994-05-09 Application filed by ユニヴェルスィテ・ドゥ・モントリオール filed Critical ユニヴェルスィテ・ドゥ・モントリオール

1996-12-10 Publication of JPH08511696A publication Critical patent/JPH08511696A/ja

2004-07-28 Application granted granted Critical

2004-07-28 Publication of JP3548175B2 publication Critical patent/JP3548175B2/ja

2019-07-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000000975 bioactive effect Effects 0.000 title claims abstract description 61
230000004048 modification Effects 0.000 title 1
238000012986 modification Methods 0.000 title 1
239000007943 implant Substances 0.000 claims abstract description 101
229910052751 metal Inorganic materials 0.000 claims abstract description 44
239000002184 metal Substances 0.000 claims abstract description 44
238000000576 coating method Methods 0.000 claims abstract description 35
239000011248 coating agent Substances 0.000 claims abstract description 34
238000000034 method Methods 0.000 claims abstract description 33
229910052717 sulfur Inorganic materials 0.000 claims abstract description 19
229910052760 oxygen Inorganic materials 0.000 claims abstract description 15
230000010354 integration Effects 0.000 claims abstract description 12
230000006641 stabilisation Effects 0.000 claims abstract description 12
238000011105 stabilization Methods 0.000 claims abstract description 12
230000008467 tissue growth Effects 0.000 claims abstract description 12
230000004071 biological effect Effects 0.000 claims abstract description 10
229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
239000010936 titanium Substances 0.000 claims description 51
229910052719 titanium Inorganic materials 0.000 claims description 46
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 45
210000000988 bone and bone Anatomy 0.000 claims description 41
102000004169 proteins and genes Human genes 0.000 claims description 33
108090000623 proteins and genes Proteins 0.000 claims description 33
210000003298 dental enamel Anatomy 0.000 claims description 19
102000004264 Osteopontin Human genes 0.000 claims description 15
108010081689 Osteopontin Proteins 0.000 claims description 15
125000000524 functional group Chemical group 0.000 claims description 14
238000004140 cleaning Methods 0.000 claims description 12
238000005498 polishing Methods 0.000 claims description 9
102000007325 Amelogenin Human genes 0.000 claims description 8
108010007570 Amelogenin Proteins 0.000 claims description 8
BMRUPFOULWJOAL-UHFFFAOYSA-N butan-1-ol;methanol;perchloric acid Chemical compound OC.CCCCO.OCl(=O)(=O)=O BMRUPFOULWJOAL-UHFFFAOYSA-N 0.000 claims description 7
239000000356 contaminant Substances 0.000 claims description 7
239000008363 phosphate buffer Substances 0.000 claims description 7
230000001737 promoting effect Effects 0.000 claims description 7
239000002356 single layer Substances 0.000 claims description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
230000021164 cell adhesion Effects 0.000 claims description 6
125000000217 alkyl group Chemical group 0.000 claims description 5
125000005103 alkyl silyl group Chemical group 0.000 claims description 5
238000006392 deoxygenation reaction Methods 0.000 claims description 5
108090000765 processed proteins & peptides Proteins 0.000 claims description 5
IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 4
102000001191 Collagen Type VIII Human genes 0.000 claims description 4
108010069526 Collagen Type VIII Proteins 0.000 claims description 4
108010028750 Integrin-Binding Sialoprotein Proteins 0.000 claims description 4
102000016921 Integrin-Binding Sialoprotein Human genes 0.000 claims description 4
238000010405 reoxidation reaction Methods 0.000 claims description 4
102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 3
108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 3
102000007547 Laminin Human genes 0.000 claims description 3
108010085895 Laminin Proteins 0.000 claims description 3
229940112869 bone morphogenetic protein Drugs 0.000 claims description 3
102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims description 2
102000004506 Blood Proteins Human genes 0.000 claims description 2
108010017384 Blood Proteins Proteins 0.000 claims description 2
102100027992 Casein kinase II subunit beta Human genes 0.000 claims description 2
101710158100 Casein kinase II subunit beta Proteins 0.000 claims description 2
102000004266 Collagen Type IV Human genes 0.000 claims description 2
108010042086 Collagen Type IV Proteins 0.000 claims description 2
108010067306 Fibronectins Proteins 0.000 claims description 2
102000016359 Fibronectins Human genes 0.000 claims description 2
101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims description 2
BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 claims description 2
108090000573 Osteocalcin Proteins 0.000 claims description 2
102000004067 Osteocalcin Human genes 0.000 claims description 2
102000009890 Osteonectin Human genes 0.000 claims description 2
108010077077 Osteonectin Proteins 0.000 claims description 2
102000016611 Proteoglycans Human genes 0.000 claims description 2
108010067787 Proteoglycans Proteins 0.000 claims description 2
108010009583 Transforming Growth Factors Proteins 0.000 claims description 2
102000009618 Transforming Growth Factors Human genes 0.000 claims description 2
230000002378 acidificating effect Effects 0.000 claims description 2
230000003635 deoxygenating effect Effects 0.000 claims description 2
229950006137 dexfosfoserine Drugs 0.000 claims description 2
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 2
235000011180 diphosphates Nutrition 0.000 claims description 2
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 claims description 2
USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 claims description 2
108010064470 polyaspartate Proteins 0.000 claims description 2
150000003180 prostaglandins Chemical class 0.000 claims description 2
125000000896 monocarboxylic acid group Chemical group 0.000 claims 11
229910003925 SiC 1 Inorganic materials 0.000 claims 4
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
239000012535 impurity Substances 0.000 claims 1
229940094443 oxytocics prostaglandins Drugs 0.000 claims 1
UNQNIRQQBJCMQR-UHFFFAOYSA-N phosphorine Chemical compound C1=CC=PC=C1 UNQNIRQQBJCMQR-UHFFFAOYSA-N 0.000 claims 1
102000004196 processed proteins & peptides Human genes 0.000 claims 1
238000000746 purification Methods 0.000 claims 1
229910052799 carbon Inorganic materials 0.000 abstract description 10
229910052710 silicon Inorganic materials 0.000 abstract description 4
230000008569 process Effects 0.000 abstract description 2
210000001519 tissue Anatomy 0.000 description 21
239000010410 layer Substances 0.000 description 17
210000000981 epithelium Anatomy 0.000 description 15
230000001464 adherent effect Effects 0.000 description 12
238000001228 spectrum Methods 0.000 description 11
239000000758 substrate Substances 0.000 description 11
239000000463 material Substances 0.000 description 10
102000002260 Alkaline Phosphatase Human genes 0.000 description 9
108020004774 Alkaline Phosphatase Proteins 0.000 description 9
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
210000004027 cell Anatomy 0.000 description 9
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
239000011593 sulfur Substances 0.000 description 9
238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 8
150000003573 thiols Chemical class 0.000 description 8
125000004429 atom Chemical group 0.000 description 7
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
210000004268 dentin Anatomy 0.000 description 6
229910052500 inorganic mineral Inorganic materials 0.000 description 6
239000011707 mineral Substances 0.000 description 6
239000000126 substance Substances 0.000 description 6
210000001053 ameloblast Anatomy 0.000 description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
210000002469 basement membrane Anatomy 0.000 description 5
210000002256 epithelial attachment Anatomy 0.000 description 5
239000012044 organic layer Substances 0.000 description 5
239000001301 oxygen Substances 0.000 description 5
239000011148 porous material Substances 0.000 description 5
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
239000004568 cement Substances 0.000 description 4
239000013078 crystal Substances 0.000 description 4
210000002919 epithelial cell Anatomy 0.000 description 4
210000002744 extracellular matrix Anatomy 0.000 description 4
239000010931 gold Substances 0.000 description 4
229910052737 gold Inorganic materials 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
125000004434 sulfur atom Chemical group 0.000 description 4
102000002322 Egg Proteins Human genes 0.000 description 3
108010000912 Egg Proteins Proteins 0.000 description 3
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
108010089430 Phosphoproteins Proteins 0.000 description 3
102000007982 Phosphoproteins Human genes 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000005842 biochemical reaction Methods 0.000 description 3
230000002308 calcification Effects 0.000 description 3
125000004432 carbon atom Chemical group C* 0.000 description 3
235000013345 egg yolk Nutrition 0.000 description 3
210000002969 egg yolk Anatomy 0.000 description 3
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
230000035876 healing Effects 0.000 description 3
238000003119 immunoblot Methods 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
210000002303 tibia Anatomy 0.000 description 3
238000002211 ultraviolet spectrum Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
101001121466 Rattus norvegicus Osteopontin Proteins 0.000 description 2
101000703459 Rattus norvegicus Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 description 2
229910000771 Vitallium Inorganic materials 0.000 description 2
238000000026 X-ray photoelectron spectrum Methods 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000009471 action Effects 0.000 description 2
238000013019 agitation Methods 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
210000000250 cementoblast Anatomy 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000011109 contamination Methods 0.000 description 2
230000007547 defect Effects 0.000 description 2
239000007857 degradation product Substances 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000001493 electron microscopy Methods 0.000 description 2
210000001080 enamel organ Anatomy 0.000 description 2
238000007429 general method Methods 0.000 description 2
238000007654 immersion Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
210000004347 intestinal mucosa Anatomy 0.000 description 2
238000002372 labelling Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000011368 organic material Substances 0.000 description 2
238000010883 osseointegration Methods 0.000 description 2
210000000963 osteoblast Anatomy 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
230000008288 physiological mechanism Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
238000007586 pull-out test Methods 0.000 description 2
238000010992 reflux Methods 0.000 description 2
230000008439 repair process Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
210000004872 soft tissue Anatomy 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
229910052715 tantalum Inorganic materials 0.000 description 2
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
230000009772 tissue formation Effects 0.000 description 2
230000017423 tissue regeneration Effects 0.000 description 2
239000000602 vitallium Substances 0.000 description 2
JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
KHKPWLATYZRQCI-UHFFFAOYSA-N 16-aminohexadecane-1-thiol Chemical compound NCCCCCCCCCCCCCCCCS KHKPWLATYZRQCI-UHFFFAOYSA-N 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
BTJIUGUIPKRLHP-UHFFFAOYSA-M 4-nitrophenolate Chemical compound [O-]C1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-M 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
229910000531 Co alloy Inorganic materials 0.000 description 1
229910000599 Cr alloy Inorganic materials 0.000 description 1
102400001058 Dentin phosphoprotein Human genes 0.000 description 1
208000032767 Device breakage Diseases 0.000 description 1
102100035094 Enamelin Human genes 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
229910001182 Mo alloy Inorganic materials 0.000 description 1
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
238000003917 TEM image Methods 0.000 description 1
229910001069 Ti alloy Inorganic materials 0.000 description 1
208000031737 Tissue Adhesions Diseases 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
150000001335 aliphatic alkanes Chemical class 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
229910052586 apatite Inorganic materials 0.000 description 1
239000010953 base metal Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000033558 biomineral tissue development Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
210000002805 bone matrix Anatomy 0.000 description 1
230000010072 bone remodeling Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000005210 cementogenesis Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
230000008859 change Effects 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
239000011651 chromium Substances 0.000 description 1
230000008045 co-localization Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
239000002131 composite material Substances 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
230000002950 deficient Effects 0.000 description 1
239000004053 dental implant Substances 0.000 description 1
108010088492 dentin sialophosphoprotein Proteins 0.000 description 1
230000008021 deposition Effects 0.000 description 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
229960003957 dexamethasone Drugs 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000010393 epithelial cell migration Effects 0.000 description 1
210000005081 epithelial layer Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000010285 flame spraying Methods 0.000 description 1
239000011888 foil Substances 0.000 description 1
-1 for example Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
210000004195 gingiva Anatomy 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
210000004349 growth plate Anatomy 0.000 description 1
210000004394 hip joint Anatomy 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
229910052588 hydroxylapatite Inorganic materials 0.000 description 1
210000004283 incisor Anatomy 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
229910001092 metal group alloy Inorganic materials 0.000 description 1
239000007769 metal material Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000001000 micrograph Methods 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000011733 molybdenum Substances 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
QJAOYSPHSNGHNC-UHFFFAOYSA-N octadecane-1-thiol Chemical compound CCCCCCCCCCCCCCCCCCS QJAOYSPHSNGHNC-UHFFFAOYSA-N 0.000 description 1
230000000399 orthopedic effect Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
239000011049 pearl Substances 0.000 description 1
VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
238000007750 plasma spraying Methods 0.000 description 1
230000010287 polarization Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
238000002278 reconstructive surgery Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000012260 resinous material Substances 0.000 description 1
239000012261 resinous substance Substances 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000002094 self assembled monolayer Substances 0.000 description 1
239000013545 self-assembled monolayer Substances 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
238000005211 surface analysis Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
150000007944 thiolates Chemical class 0.000 description 1
108010022248 tuftelin Proteins 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1

Images

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oral & Maxillofacial Surgery (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Nanotechnology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Mathematical Physics (AREA)
Theoretical Computer Science (AREA)
Crystallography & Structural Chemistry (AREA)
Biomedical Technology (AREA)
Materials For Medical Uses (AREA)
Prostheses (AREA)

JP52476394A 1993-05-10 1994-05-09 結合改良のためのバイオアクティブ共役体による移植片表面の改質 Expired - Fee Related JP3548175B2 (ja)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US5875393A	1993-05-10	1993-05-10
US08/058,753		1993-05-10
US22634594A	1994-04-12	1994-04-12
US08/226,345		1994-04-12
PCT/CA1994/000257 WO1994026321A1 (en)	1993-05-10	1994-05-09	Modification of implant surface with bioactive conjugates for improved integration

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2003432701A Division JP2004154586A (ja)	1993-05-10	2003-12-26	結合改良のためのバイオアクティブ共役体による移植片表面の改質

Publications (2)

Publication Number	Publication Date
JPH08511696A JPH08511696A (ja)	1996-12-10
JP3548175B2 true JP3548175B2 (ja)	2004-07-28

Family

ID=26737995

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP52476394A Expired - Fee Related JP3548175B2 (ja)	1993-05-10	1994-05-09	結合改良のためのバイオアクティブ共役体による移植片表面の改質
JP2003432701A Pending JP2004154586A (ja)	1993-05-10	2003-12-26	結合改良のためのバイオアクティブ共役体による移植片表面の改質

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2003432701A Pending JP2004154586A (ja)	1993-05-10	2003-12-26	結合改良のためのバイオアクティブ共役体による移植片表面の改質

Country Status (12)

Country	Link
EP (1)	EP0697896B1 (da)
JP (2)	JP3548175B2 (da)
KR (1)	KR100302545B1 (da)
AT (1)	ATE175581T1 (da)
AU (1)	AU690113B2 (da)
BR (1)	BR9406647A (da)
CA (1)	CA2162114A1 (da)
DE (1)	DE69415974T2 (da)
DK (1)	DK0697896T3 (da)
ES (1)	ES2131684T3 (da)
GR (1)	GR3029949T3 (da)
WO (1)	WO1994026321A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5861032A (en) *	1996-01-31	1999-01-19	Surface Genesis, Inc.	Medical device having a biocompatible coating and oxidation method of coupling therefor
KR0176334B1 (ko) *	1996-08-19	1999-04-01	박원훈	내인체 감염성 삽입금속표면의 코팅방법 및 그 치료기술
WO1999008730A1 (en)	1997-08-15	1999-02-25	Children's Medical Center Corporation	Osteopontin coated surfaces and methods of use
AU2002324011B2 (en) *	1997-08-15	2006-06-01	Children's Medical Center Corporation	Osteopontin coated surfaces and methods of use
CH694935A5 (de)	2000-07-26	2005-09-30	Straumann Holding Ag	Oberflaechenmodifizierte Implantate.
DE10037850A1 (de)	2000-08-01	2002-02-21	Herbert P Jennissen	Verfahren zur Herstellung bioaktiver Implantatoberflächen
AU2001221607A1 (en)	2000-11-20	2002-05-27	Ecole Polytechnique Federale De Lausanne (Epfl)	Endosseous implant
CH695985A5 (de) *	2002-01-21	2006-11-15	Straumann Holding Ag	Oberflächenmodifizierte Implantate.
KR101013999B1 (ko)	2004-03-19	2011-02-14	재단법인서울대학교산학협력재단	표면에 골조직 형성 증진 펩타이드가 고정된 차폐막 및임플란트
CA2626637A1 (en) *	2005-10-19	2007-04-26	Kenton W. Gregory	Method of using and producing tropoelastin and tropoelastin biomaterials
EP1991284A4 (en) *	2006-02-01	2012-07-04	Jake Barralet	BIOIMPLANTS FOR USE IN TISSUE GROWTH
CN102268713B (zh) *	2011-06-29	2013-10-23	武汉科技大学	一种不锈钢表面纳米孔阵列薄膜及其制备方法
JP6148487B2 (ja) *	2012-05-31	2017-06-14	久保木　芳徳	チタン−タンパク質複合体の製造方法
EP2919920B1 (en)	2012-11-19	2020-07-08	Institut Curie	Method for grafting polymers on metallic substrates
CN103882442B (zh) *	2014-04-16	2015-09-30	武汉科技大学	一种不锈钢表面三维纳米碳薄膜及其制备方法
KR101544357B1 (ko)	2014-04-23	2015-08-13	주식회사 비앤메디	표면처리된 티타늄 임플란트의 전해연마를 이용한 표면개질 방법
KR102921957B1 (ko) *	2022-09-13	2026-02-05	한국생산기술연구원	티타늄 임플란트 표면 처리 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3241589A1 (de) *	1982-11-10	1984-05-17	Pfaudler-Werke Ag, 6830 Schwetzingen	Implantate und verfahren zu deren herstellung
ATE196728T1 (de) *	1988-07-22	2000-10-15	Surmodics Inc	Herstellung von polymeren oberflächen
CA2118496C (en) *	1992-04-24	2005-01-11	Roger Randall Charles New	Method of reducing microorganism adhesion

1994
- 1994-05-09 WO PCT/CA1994/000257 patent/WO1994026321A1/en not_active Ceased
- 1994-05-09 KR KR1019950705019A patent/KR100302545B1/ko not_active Expired - Fee Related
- 1994-05-09 DK DK94915005T patent/DK0697896T3/da active
- 1994-05-09 AT AT94915005T patent/ATE175581T1/de not_active IP Right Cessation
- 1994-05-09 BR BR9406647A patent/BR9406647A/pt not_active Application Discontinuation
- 1994-05-09 CA CA002162114A patent/CA2162114A1/en not_active Abandoned
- 1994-05-09 AU AU66434/94A patent/AU690113B2/en not_active Ceased
- 1994-05-09 JP JP52476394A patent/JP3548175B2/ja not_active Expired - Fee Related
- 1994-05-09 DE DE69415974T patent/DE69415974T2/de not_active Expired - Fee Related
- 1994-05-09 EP EP94915005A patent/EP0697896B1/en not_active Expired - Lifetime
- 1994-05-09 ES ES94915005T patent/ES2131684T3/es not_active Expired - Lifetime
1999
- 1999-04-14 GR GR990401039T patent/GR3029949T3/el unknown
2003
- 2003-12-26 JP JP2003432701A patent/JP2004154586A/ja active Pending

Also Published As

Publication number	Publication date
KR100302545B1 (ko)	2001-11-22
EP0697896A1 (en)	1996-02-28
BR9406647A (pt)	1996-03-12
WO1994026321A1 (en)	1994-11-24
JPH08511696A (ja)	1996-12-10
KR960702326A (ko)	1996-04-27
AU6643494A (en)	1994-12-12
ES2131684T3 (es)	1999-08-01
DE69415974T2 (de)	1999-08-19
CA2162114A1 (en)	1994-11-24
DK0697896T3 (da)	1999-09-06
ATE175581T1 (de)	1999-01-15
EP0697896B1 (en)	1999-01-13
GR3029949T3 (en)	1999-07-30
DE69415974D1 (de)	1999-02-25
JP2004154586A (ja)	2004-06-03
AU690113B2 (en)	1998-04-23

Legal Events

Date	Code	Title	Description
2004-01-05	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031226
2004-03-17	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040318
2004-03-31	TRDD	Decision of grant or rejection written
2004-04-05	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040402
2004-04-22	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040416
2004-04-23	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2007-04-23	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
US5824651A (en)	1998-10-20	Process for modification of implant surface with bioactive conjugates for improved integration
US5876454A (en)	1999-03-02	Modified implant with bioactive conjugates on its surface for improved integration
AU690113B2 (en)	1998-04-23	Modification of implant surface with bioactive conjugates for improved integration
de Jonge et al.	2008	Organic–inorganic surface modifications for titanium implant surfaces
CA2138270C (en)	2000-08-08	Prosthetic devices having enhanced osteogenic properties
Al-Sanabani et al.	2013	Application of calcium phosphate materials in dentistry
Stanford et al.	1991	The concept of osseointegration and bone matrix expression
EP1385449B1 (de)	2006-07-12	Biologisch funktionalisierte, metabolisch induktive implantatoberflächen
Xue et al.	2005	In vivo evaluation of plasma-sprayed titanium coating after alkali modification
Kim et al.	2008	Biomimetic approach to dental implants
US8545625B2 (en)	2013-10-01	Materials for dental and biomedical application
Chen et al.	2022	Current surface modification strategies to improve the binding efficiency of emerging biomaterial polyetheretherketone (PEEK) with bone and soft tissue: A literature review
DE3241589A1 (de)	1984-05-17	Implantate und verfahren zu deren herstellung
CN1268307C (zh)	2006-08-09	再生性骨植入物
WO2008146113A2 (en)	2008-12-04	Process for coating a surface of a metal element to increase osteointegration thereof and prosthetic device including said element
EP2118136B1 (en)	2010-07-28	Consensus peptide
Takeshita et al.	1997	Study of bone formation around dense hydroxyapatite implants using light microscopy, image processing and confocal laser scanning microscopy
JPWO2013157638A1 (ja)	2015-12-21	ＨＡｐ／Ｃｏｌ複合体によって被覆された生体材料
WO2014024171A1 (en)	2014-02-13	Process for preparation of a biocompatible coating for bone grafts as well as coating and implant obtained therewith
US20070009568A1 (en)	2007-01-11	Methods for immobilizing molecules on surfaces
Padial-Molina et al.	2009	Biomimetic ceramics in implant dentistry
Balint et al.	2021	Advanced nanomaterials and coated surfaces for orthopedic implants–a review
Todescan et al.	1994	Reconstituted Collagen Produces Different Healing Reactions in Bony and Soft Tissue Peri-implant Compartments.
Sharma et al.	2014	Implant surface micro-design
CN1220169A (zh)	1999-06-23	一种涂有骨形态发生蛋白的人工关节及其制造方法